Article Versions Notes

Sánchez-Somolinos M, Díaz-Navarro M, Benjumea A, Tormo M, Matas J, Vaquero J, Muñoz P, Sanz-Ruíz P, Guembe M. Determination of the Elution Capacity of Dalbavancin in Bone Cements: New Alternative for the Treatment of Biofilm-Related Peri-Prosthetic Joint Infections Based on an In Vitro Study. Antibiotics. 2022; 11(10):1300. https://doi.org/10.3390/antibiotics11101300

Sánchez-Somolinos, Mar, Marta Díaz-Navarro, Antonio Benjumea, Marta Tormo, José Matas, Javier Vaquero, Patricia Muñoz, Pablo Sanz-Ruíz, and María Guembe. 2022. "Determination of the Elution Capacity of Dalbavancin in Bone Cements: New Alternative for the Treatment of Biofilm-Related Peri-Prosthetic Joint Infections Based on an In Vitro Study" Antibiotics 11, no. 10: 1300. https://doi.org/10.3390/antibiotics11101300

Sánchez-Somolinos, M., Díaz-Navarro, M., Benjumea, A., Tormo, M., Matas, J., Vaquero, J., Muñoz, P., Sanz-Ruíz, P., & Guembe, M. (2022). Determination of the Elution Capacity of Dalbavancin in Bone Cements: New Alternative for the Treatment of Biofilm-Related Peri-Prosthetic Joint Infections Based on an In Vitro Study. Antibiotics, 11(10), 1300. https://doi.org/10.3390/antibiotics11101300